Health ❯ Healthcare ❯ Regulatory Affairs

European Medicines Agency

Marketing Authorization Drug Approval Process Drug Safety Drug Regulation Prac Recommendations CHMP Review Process EU-M4all Programme Conditional Marketing Authorization Approval Process CHMP Opinions Orphan Medicinal Products CHMP Opinion Drug Reviews Drug Approval Committee for Medicinal Products for Human Use

11 ARTICLES

last mo.

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

Private pharmacies are already dispensing the daily oral semaglutide tablet, which changes access patterns, raises monitoring needs, increases counterfeit risk.

4 ARTICLES

3mo ago

EU Panel Recommends Braftovi Plus Cetuximab and FOLFOX for First‑Line BRAF‑Mutant Colorectal Cancer

4 ARTICLES

3mo ago

CHMP Backs Expanded EU Use of Mounjaro for Diabetes in Patients 10+ and Adult Weight Management

3 ARTICLES

10mo ago

EMA Panel Recommends Rejecting Rezurock for Chronic Graft-Versus-Host Disease in EU

9 ARTICLES

last yr.

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

European Medicines Agency

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

EU Panel Recommends Braftovi Plus Cetuximab and FOLFOX for First‑Line BRAF‑Mutant Colorectal Cancer

EMA Recommends Jascayd for Two Progressive Lung Fibrosis Conditions

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

EMA Panel Backs Higher 7.2 mg Wegovy Dose for Obesity

CHMP Backs Expanded EU Use of Mounjaro for Diabetes in Patients 10+ and Adult Weight Management

EMA Panel Recommends Rejecting Rezurock for Chronic Graft-Versus-Host Disease in EU

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy